Debra Goff

Image
Debbie Goff

Debra Goff

Title
Professor - Practice
Unit / Department / Division
Pharmacy Practice and Science
Address
368 Parks Hall
Email Address
Phone Number

Education

  • 1983, Residency, University of Illinois at Chicago
  • 1982, PharmD, University of Illinois at Chicago
  • 1980, BS Pharmacy, University of Illinois at Chicago

Honors

  • Pharmacy Times Lifetime Achievement Award finalist 2019
  • Fellow of the Infectious Diseases Society of America 2019
  • Distinguished International Outreach and Engagement Award, 2019
  • Ohio Society of Hospital Pharmacy Research Award, 2018
  • American College of Clinical Pharmacy Global Health Award, 2017
  • OSU International Emerging Outreach and Engagement recipient, 2016
  • Fellow of the American College of Clinical Pharmacy, 2006
  • OSUMC Leadership Council for Clinical Value Enhancement for developing the “Community-Acquired Pneumonia in Immunocompetent Adult Patients” Clinical Practice Guideline, 2002

Journal Articles

  • Brower, K.I.; Hecke, A.; Mangino, J.E.; Gerlach, A.T. et al. Duration of Antibiotic Therapy for General Medicine and General Surgery Patients Throughout Transitions of Care: An Antibiotic Stewardship Opportunity for Noninfectious Disease Pharmacists Hospital Pharmacy. 2020 Jan; .
  • Rhodes, N.J.; Wagner, J.L.; Davis, S.L.; Bosso, J.A. et al. Trends in and Predictors of Carbapenem Consumption across North American Hospitals: Results from a Multicenter Survey by the MAD-ID Research Network. Antimicrobial agents and chemotherapy. 2019 Jul; 63(7):.
  • Goff, D.A.; Kullar, R.; Laxminarayan, R.; Mendelson, M. et al. Twitter to engage, educate, and advocate for global antibiotic stewardship and antimicrobial resistance. Lancet Infect Dis. 2019 Mar; 19(3):229-231.
  • Pulcini, C.; Binda, F.; Lamkang, A.S.; Trett, A. et al. Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach. Clin Microbiol Infect. 2019 Jan; 25(1):20-25.
  • Goff, D.A. Antibiotic Stewardship: The Health of the World Depends on It. Hosp Pharm. 2018 Jul; 53(4):214-216.
  • Srinivas, P.; Hunt, L.N.; Pouch, S.M.; Thomas, K. et al. Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates. Diagn Microbiol Infect Dis. 2018 Jun; 91(2):194-198.
  • Malan, L.; Labuschagne, Q.; Brechtelsbauer, E.; Goff, D.A. et al. Sustainable Access to Antimicrobials; A Missing Component to Antimicrobial Stewardship-A Tale of Two Countries. Front Public Health. 2018 Jan; 6 324.
  • Bauer, K.A.; Johnston, J.E.W.; Wenzler, E.; Goff, D.A. et al. Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection. Anaerobe. 2017 Dec; 48 1-6.
  • Wenzler, E.; Wang, F.; Goff, D.A.; Prier, B. et al. Reply to Dilworth et al. Clin Infect Dis. 2017 Nov; 65(11):1957-1958.
  • Sartelli, M.; Kluger, Y.; Ansaloni, L.; Carlet, J. et al. A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway Surgical Infections. 2017 Nov; 18(8):846-853.
  • Schellack, N.; Benjamin, D.; Brink, A.; Duse, A. et al. A situational analysis of current antimicrobial governance, regulation, and utilization in South Africa. Int J Infect Dis. 2017 Nov; 64 100-106.
  • Kullar, R.; Goff, D.A.; Bauer, K.A.; File, T.M. Reply to Bush and Kaye. Clin Infect Dis. 2017 Oct; 65(9):1596.
  • Goff, D.A.; Mendelson, M. Antibiotic stewardship hits a home run for patients. Lancet Infect Dis. 2017 Sep; 17(9):892-893.
  • Wenzler, E.; Wang, F.; Goff, D.A.; Prier, B. et al. An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia. Clin Infect Dis. 2017 Jul; 65(2):194-200.
  • Ubaka, C.; Brechtelsbauer, E.; Goff, D.A. International Mentoring Programs: Leadership Opportunities to Enhance Worldwide Pharmacy Practice. Hosp Pharm. 2017 Jul; 52(7):471-477.
  • Wenzler, E.; Goff, D.A.; Humphries, R.; Goldstein, E.J.C. Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections. Infect Dis Ther. 2017 Jun; 6(2):149-172.
  • Bremmer, D.N.; Balada-Llasat, J-M.; Goff, D.A.; Bauer, K.A. Ceftriaxone Etest non-susceptible methicillin susceptible Staphylococcus aureus time-kill responses. Diagn Microbiol Infect Dis. 2017 Jun; 88(2):192-194.
  • Goff, D.A.; Kullar, R.; Bauer, K.A.; File, T.M. Eight Habits of Highly Effective Antimicrobial Stewardship Programs to Meet the Joint Commission Standards for Hospitals. Clin Infect Dis. 2017 Apr; 64(8):1134-1139.
  • Goff, D.A.; Karam, G.H.; Haines, S.T. Impact of a national antimicrobial stewardship mentoring program: Insights and lessons learned. Am J Health Syst Pharm. 2017 Feb; 74(4):224-231.
  • Goff, D.A.; Kullar, R.; Goldstein, E.J.C.; Gilchrist, M. et al. A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. Lancet Infect Dis. 2017 Feb; 17(2):e56-e63.
  • Goff, D.A.; File, T.M. The risk of prescribing antibiotics "just-in-case" there is infection Seminars in Colon and Rectal Surgery. 2017 Jan; .
  • Tacconelli, E.; Carrara, E.; Savoldi, A.; Harbarth, S. et al. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis The Lancet Infectious Diseases. 2017 Jan; .
  • Bauer, K.A.; Mangino, J.E.; Paolo-Hohman, D.; Goff, D.A. Outpatient Parenteral Antimicrobial Therapy and Antimicrobial Stewardship: Implementation of a Structured Approach to Improve Patient Outcomes Infectious Diseases in Clinical Practice. 2016 Nov; 24(6):328-331.
  • Bremmer, D.N.; Bauer, K.A.; Pouch, S.M.; Thomas, K. et al. Correlation of Checkerboard Synergy Testing with Time-Kill Analysis and Clinical Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Respiratory Infections. Antimicrob Agents Chemother. 2016 Nov; 60(11):6892-6895.
  • Goff, D.A.; Jones, C.; Toney, B.; Nwomeh, B.C. et al. Use of Twitter to Educate and Engage Surgeons in Infectious Diseases and Antimicrobial Stewardship Infectious Diseases in Clinical Practice. 2016 Nov; 24(6):324-327.
  • Brink, A.J.; Messina, A.P.; Feldman, C.; Richards, G.A. et al. Antimicrobial stewardship across 47 South African hospitals: an implementation study. Lancet Infect Dis. 2016 Sep; 16(9):1017-1025.
  • Goldstein, E.J.C.; Goff, D.A.; Reeve, W.; Naumovski, S. et al. Approaches to Modifying the Behavior of Clinicians Who Are Noncompliant With Antimicrobial Stewardship Program Guidelines. Clin Infect Dis. 2016 Aug; 63(4):532-538.
  • Horn, D.; Goff, D.; Khandelwal, N.; Spalding, J. et al. Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial. J Med Econ. 2016 Jul; 19(7):728-734.
  • Goff, D.A.; File, T.M. The Evolving Role of Antimicrobial Stewardship in Management of Multidrug Resistant Infections. Infect Dis Clin North Am. 2016 Jun; 30(2):539-551.
  • Wenzler, E.; Wong, J.R.; Goff, D.A.; Jankowski, C.A. et al. Controversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials. Antibiotics (Basel). 2016 Jan; 5(1):.
  • Kolman, S.; Geertsema, H.; Van Den Bergh, D.; Goff, D. Engaging pharmacy personnel in antimicrobial stewardship using a novel method of teaching SA Pharmaceutical Journal. 2016 Jan; 83(1):25-29.
  • Moise, P.A.; Culshaw, D.L.; Wong-Beringer, A.; Bensman, J. et al. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. Clin Ther. 2016 Jan; 38(1):16-30.
  • Wenzler, E.; Goff, D.A.; Mangino, J.E.; Reed, E.E. et al. Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia. Diagn Microbiol Infect Dis. 2016 Jan; 84(1):63-68.
  • Goff, D.A.; Mendelson, M. Putting your money where your mouth is: Scotland's attack on MRSA pays off. Lancet Infect Dis. 2015 Dec; 15(12):1369-1370.
  • Goff, D.A.; Rybak, M.J. Global Antimicrobial Stewardship: Challenges and Successes from Frontline Stewards. Infect Dis Ther. 2015 Sep; 4(Suppl 1):1-3.
  • Messina, A.P.; van den Bergh, D.; Goff, D.A. Antimicrobial Stewardship with Pharmacist Intervention Improves Timeliness of Antimicrobials Across Thirty-three Hospitals in South Africa. Infect Dis Ther. 2015 Sep; 4(Suppl 1):5-14.
  • Bauer, K.A.; Goff, D.A. When diagnostic technology is ahead of the hospital budget: what is antimicrobial stewardship to do? Clin Infect Dis. 2015 Aug; 61(3):486-487.
  • Toney, B.; Goff, D.A.; Weber, R.J. Social Media As a Leadership Tool for Pharmacists. Hosp Pharm. 2015 Jul; 50(7):644-648.
  • Goff, D.A.; Kullar, R.; Newland, J.G. Review of Twitter for infectious diseases clinicians: useful or a waste of time? Clin Infect Dis. 2015 May; 60(10):1533-1540.
  • Goff, D.A.; Van Den Bergh, D. Twitter: A tool to improve healthcare professionals’ awareness of antimicrobial resistance and antimicrobial stewardship South African Medical Journal. 2015 Jan; 105(5):427-430.
  • Goff, D.A.; Kaye, K.S. Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii. Clin Infect Dis. 2014 Dec; 59 Suppl 6 S365-S366.
  • Goff, D.A.; Mendelson, M. Is it time for an antibiotic prenuptial agreement? Lancet Infect Dis. 2014 Dec; 14(12):1168-1169.
  • Goff, D.A.; Bauer, K.A.; Mangino, J.E. Bad bugs need old drugs: a stewardship program's evaluation of minocycline for multidrug-resistant Acinetobacter baumannii infections. Clin Infect Dis. 2014 Dec; 59 Suppl 6 S381-S387.
  • Bauer, K.A.; Perez, K.K.; Forrest, G.N.; Goff, D.A. Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis. 2014 Oct; 59 Suppl 3 S134-S145.
  • Sakoulas, G.; Moise, P.A.; Casapao, A.M.; Nonejuie, P. et al. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline. Clin Ther. 2014 Oct; 36(10):1317-1333.
  • Vargo, C.A.; Bauer, K.A.; Mangino, J.E.; Johnston, J.E.W. et al. An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series. Pharmacotherapy. 2014 Sep; 34(9):901-909.
  • Kullar, R.; Goff, D.A. Transformation of antimicrobial stewardship programs through technology and informatics. Infect Dis Clin North Am. 2014 Jun; 28(2):291-300.
  • Casapao, A.M.; Davis, S.L.; Barr, V.O.; Klinker, K.P. et al. Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy. Antimicrob Agents Chemother. 2014 May; 58(5):2541-2546.
  • Reed, E.E.; West, J.E.; Keating, E.A.; Pancholi, P. et al. Improving the management of candidemia through antimicrobial stewardship interventions. Diagn Microbiol Infect Dis. 2014 Feb; 78(2):157-161.
  • Hawser, S.P.; Badal, R.E.; Bouchillon, S.K.; Hoban, D.J. et al. Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011. J Infect. 2014 Jan; 68(1):71-76.
  • Wenzler, E.; Goff, D.A.; Bazan, J.A.; Bauer, K.A. Clinical outcomes in patients with ceftriaxone-resistant streptococcus pneumoniae pneumonia Infectious Diseases in Clinical Practice. 2014 Jan; 22(5):263-266.
  • Davis, S.L.; Scheetz, M.H.; Bosso, J.A.; Goff, D.A. et al. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals. Pharmacotherapy. 2013 Dec; 33(12):1256-1263.
  • Kullar, R.; Goff, D.A.; Schulz, L.T.; Fox, B.C. et al. The "epic" challenge of optimizing antimicrobial stewardship: the role of electronic medical records and technology. Clin Infect Dis. 2013 Oct; 57(7):1005-1013.
  • Moodley, A.; Mangino, J.E.; Goff, D.A. Review of infectious diseases applications for iPhone/iPad and Android: from pocket to patient. Clin Infect Dis. 2013 Oct; 57(8):1145-1154.
  • Casapao, A.M.; Kullar, R.; Davis, S.L.; Levine, D.P. et al. Multicenter study of high-dose daptomycin for treatment of enterococcal infections. Antimicrob Agents Chemother. 2013 Sep; 57(9):4190-4196.
  • Casapao, A.M.; Leonard, S.N.; Davis, S.L.; Lodise, T.P. et al. Clinical outcomes in patients with heterogeneous vancomycin-intermediate staphylococcus aureus bloodstream infection Antimicrobial Agents and Chemotherapy. 2013 Sep; 57(9):4252-4259.
  • Casapao, A.M.; Leonard, S.N.; Davis, S.L.; Lodise, T.P. et al. Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection. Antimicrob Agents Chemother. 2013 Sep; 57(9):4252-4259.
  • Nicolar, D.P.; Carmeli, Y.; Crank, C.W.; Goff, D.A. et al. Carbapenem stewardship: Does ertapenem affect pseudomonas susceptibility to other carbapenem? a review of the evidence Chinese Journal of Infection and Chemotherapy. 2013 Aug; 13(3):235-240.
  • Bauer, K.A.; West, J.E.; O'Brien, J.M.; Goff, D.A. Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections. Antimicrob Agents Chemother. 2013 Jul; 57(7):2907-2912.
  • Gawronski, K.M.; Goff, D.A.; Brown, J.; Khadem, T.M. et al. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Clin Ther. 2013 Jun; 35(6):772-779.
  • Goff, D.A.; Nicolau, D.P. When pharmacodynamics trump costs: an antimicrobial stewardship program's approach to selecting optimal antimicrobial agents. Clin Ther. 2013 Jun; 35(6):766-771.
  • Bauer, K.A.; Gentene, A.J.; West, J.E.; Shidham, G. et al. An antimicrobial stewardship program's evaluation of the safety and efficacy of continuous infusion of nafcillin in the treatment of methicillin-sensitive staphylococcus aureus bacteremia Infectious Diseases in Clinical Practice. 2013 Apr; 21(2):111-113.
  • Reed, E.E.; Stevenson, K.B.; West, J.E.; Bauer, K.A. et al. Impact of formulary restriction with prior authorization by an antimicrobial stewardship program. Virulence. 2013 Feb; 4(2):158-162.
  • Wong, J.R.; Bauer, K.A.; Mangino, J.E.; Goff, D.A. Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction. Ann Pharmacother. 2012 Nov; 46(11):1484-1490.
  • Goff, D.A.; Bauer, K.A.; Reed, E.E.; Stevenson, K.B. et al. Is the "low-hanging fruit" worth picking for antimicrobial stewardship programs? Clin Infect Dis. 2012 Aug; 55(4):587-592.
  • Goff, D.A.; Rybak, M.J. Introduction to the special issue on antimicrobial stewardship. Pharmacotherapy. 2012 Aug; 32(8):663-664.
  • Goff, D.A.; Jankowski, C.; Tenover, F.C. Using rapid diagnostic tests to optimize antimicrobial selection in antimicrobial stewardship programs. Pharmacotherapy. 2012 Aug; 32(8):677-687.
  • Goff, D.A. iPhones, iPads, and medical applications for antimicrobial stewardship. Pharmacotherapy. 2012 Jul; 32(7):657-661.
  • An antimicrobial stewardship approach to combating multidrug-resistant Acinetobacter baumannii infections with monocycline Infectious Diseases in Clinical Practice. 2012 May; 20(3):.
  • Stevenson, K.B.; Balada-Llasat, J-M.; Bauer, K.; Deutscher, M. et al. The economics of antimicrobial stewardship: the current state of the art and applying the business case model. Infection control and hospital epidemiology. 2012 Apr; 33(4):389-397.
  • Nicolau, D.P.; Carmeli, Y.; Crank, C.W.; Goff, D.A. et al. Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence. Int J Antimicrob Agents. 2012 Jan; 39(1):11-15.
  • Reed, E.; Goff, D. Letter to the Editor - Pharmacy and laboratory collaboration: Response to the Editor Hospital Pharmacy. 2011 Dec; 46(12):920-921.
  • Goff, D.A. Challenges of antimicrobial stewardship programs: What's a steward to do? Infectious Diseases in Clinical Practice. 2011 Nov; 19(6):375.
  • Bauer,Karri,A; West,Jessica,E; Balada-Llasat,Joan-Miquel; Pancholi,Preeti; Stevenson,Kurt,B; Goff,Debra,A Benefits and Costs of Rapid Drug Susceptibility in Staphylococcus aureus Bacteremia Reply CLINICAL INFECTIOUS DISEASES. 2011 Apr; 52(8):1079-1080.
  • Winters, H.A.; Parbhoo, R.K.; Schafer, J.J.; Goff, D.A. Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients. Ann Pharmacother. 2011 Mar; 45(3):309-316.
  • Goff, D.A. Antimicrobial stewardship: bridging the gap between quality care and cost. Curr Opin Infect Dis. 2011 Feb; 24 Suppl 1 S11-S20.
  • Bauer, K.A.; West, J.E.; Balada-Llasat, J-M.; Pancholi, P. et al. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis. 2010 Nov; 51(9):1074-1080.
  • Bazan, J.A.; Bauer, K.A.; Hollister, A.S.; Shidham, G. et al. Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy. Pharmacotherapy. 2010 Oct; 30(10):1016-1020.
  • Schafer, J.J.; Goff, D.A.; Mangino, J.E. Doripenem: a new addition to the carbapenem class of antimicrobials. Recent Pat Antiinfect Drug Discov. 2009 Jan; 4(1):18-28.
  • Schafer, J.J.; Goff, D.A. Establishing the role of tigecycline in an era of antimicrobial resistance. Expert Rev Anti Infect Ther. 2008 Oct; 6(5):557-567.
  • Goff, D.A.; Mangino, J.E. Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem. J Infect. 2008 Aug; 57(2):123-127.
  • Goff, D.A.; Dowzicky, M.J. Prevalence and regional variation in meticillin-resistant Staphylococcus aureus (MRSA) in the USA and comparative in vitro activity of tigecycline, a glycylcycline antimicrobial. J Med Microbiol. 2007 Sep; 56(Pt 9):1189-1193.
  • Early experience with Tigecycline for ventilator associate pneumonia and bcteremia caused by multi-druge resistant Acinetobacter baumannii 2007 Jan; 980-987.
  • Brown, J.; Goff, D.A. Shorter-course antibiotic therapy for CARTIs: Is shorter better? American Journal of Managed Care. 2005 Oct; 11(SUPPL. OCT.):3-9.
  • Goff, D.A. Short-duration therapy for respiratory tract infections. Ann Pharmacother. 2004 Sep; 38(9 Suppl):S19-S23.
  • Goff, D.A. Cost effective approaches to antimicrobial use in oncology patients. Curr Opin Infect Dis. 2002 Dec; 15(6):565-568.
  • Potoski, B.A.; Mangino, J.E.; Goff, D.A. Clinical failures of linezolid and implications for the clinical microbiology laboratory. Emerg Infect Dis. 2002 Dec; 8(12):1519-1520.
  • Chakeres, D.W.; Abduljalil, A.M.; Novak, P.; Novak, V. Comparison of 1.5 and 8 tesla high-resolution magnetic resonance imaging of lacunar infarcts. Journal of computer assisted tomography. 2002 Jul; 26(4):628-632.
  • Goff, D.A.; Sierawski, S.J. Clinical experience of quinupristin-dalfopristin for the treatment of antimicrobial-resistant gram-positive infections. Pharmacotherapy. 2002 Jun; 22(6):748-758.
  • The Lancet Infectious Diseases, THE LANCET Infectious Diseases The Lancet Infectious Diseases. 2002 May; 2(5):261-261.
  • Goff, D.A.; Sierawski, S.J. Clinical experience of quinupristin-dalfopristin for the treatment of antimicrobial-resistant gram-positive infections Pharmacotherapy. 2002 Jan; 22(6 I):748-758.
  • McKinnon, P.S.; Goff, D.A.; Kern, J.W.; Devlin, J.W. et al. Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg. 2001 Dec; 136(12):1401-1408.
  • Goff, D.A.; Mangino, J.; Goff, D.; Glassman, A. et al. Review of Guidelines for Dental Antibiotic Prophylaxis and Need for Dental Stewardship CLINICAL INFECTIOUS DISEASES. Dec .
  • Goff, D.A.; van den Bergh, D.; Messina, A.; van Jaarsveld, A. et al. A cross-sector, pharmacist-led prospective cohort study of antibiotic stewardship interventions to improve compliance to national community acquired pneumonia guidelines in public and private hospitals in South Africa LANCET INFECTIOUS DISEASES. Dec .
  • Goff, D.A.; Sierawski, S.J.; Lubowski, T.J. Software-aided evaluation of antibiotic cost and coverage: Example of empiric therapy for intraperitoneal abscess infections Formulary. 2000 Jan; 35(10):842-852.
  • Goff, D.A. Determining the cost of antimicrobial therapy: A focus on fluoroquinolones Formulary. 1998 Dec; 33(7):648-656.
  • Fass, R.J.; Goff, D.A.; Sierawski, S.J. Candida infections in the surgical intensive care unit. J Antimicrob Chemother. 1996 Nov; 38(5):915-916.
  • Goff, D.A.; Sierawski, S.J.; Gabriel, M.; Siegel, J. An interdisciplinary approach to ciprofloxacin streamlining P and T. 1996 Jan; 21(10):531-536+564.
  • Goff, D.A.; Sierawski, S.J.; Fass, R.J. Cost analysis of candida infection among surgical intensive care unit patients Clinical Drug Investigation. 1996 Jan; 12(4):176-180.
  • Goff,D,A; Koletar,S,L; BUESCHING,W,J; Barnishan,J; Fass,R,J ISOLATION OF FLUCONAZOLE-RESISTANT CANDIDA-ALBICANS FROM HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE PATIENTS NEVER TREATED WITH AZOLES CLINICAL INFECTIOUS DISEASES. 1995 Jan; 20(1):77-83.
  • Thornton, J.P.; Goff, D.A.; Segal, R.; Guy, J.T. Impact of a clinical pharmacist on antibiotic prescribing. A multicenter trial. J Pharm Technol. 1991 Sep; 7(5):195-200.
  • Goff, D.; Thornton, J. Pharmacy-laboratory interactions: a unique method to control antibiotic costs. Hosp Pharm. 1989 Jan; 24(1):26-32.
  • Goff, D.A.; Spunt, A.L.; Jung, D.; Bellur, S.N. et al. Absorption characteristics of three phenytoin sodium products after administration of oral loading doses. Clin Pharm. 1984 Nov; 3(6):634-638.
  • Grussing, P.G.; Goff, D.A.; Kraus, D.M.; Mueller, C.E. Development and validation of an instrument to measure physicians' attitudes toward the clinical pharmacist's role. Drug Intell Clin Pharm. 1984 Jul; 18(7-8):635-640.